Investors with a lot of money to spend have taken a bearish stance on DexCom DXCM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday. Users can buy a one-month ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap of $30.4 billion, the company specializes in continuous glucose ...

Progress in medicine could lead to a smaller target market for DexCom. However, the company is expanding opportunities through innovation. On the other hand, DexCom has attractive opportunities ...

In this article, we are going to take a look at where Dexcom, Inc. (NASDAQ ... the chairman of MIT's economics department, the annual cost of treating 40% of obese Americans at the current rate ...

Bearish flow noted in DexCom (DXCM) with 11,940 puts trading, or 4x expected. Most active are 12/27 weekly 59 puts and 12/27 weekly 77 puts, with total volume in those strikes near 10,900 contracts.

Shares of DexCom Inc. DXCM slid 2.58% to $78.92 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.19% to 6,075.11 and ...

Partnership will enable two-way data flow between Dexcom glucose biosensors and apps and Oura Ring and the Oura App, providing a first-of-its-kind metabolic health management experience Co ...